|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Clinical research trials and Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma. Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma clinical trial. Test subjects typically receive the most effective healthcare possible for their Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma  Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
For Condition: recurrent grade 2 follicular lymphoma,recurrent grade 1 follicular lymphoma,recurrent grade 3 follicular lymphoma
Status: Recruiting
Sponsor(s): EBMT Solid Tumors Working Party , British National Lymphoma Investigation
Synopsis: RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. It is not yet known if combination chemotherapy plus peripheral stem cell transplantation is more effective with or without rituximab for non-Hodgkin's lymphoma. PURPOSE: Randomizedphase III trial to compare the effectiveness of combination chemotherapy plus peripheral stem cell transplantation with or without rituximab in treating patients who have relapsed non-Hodgkin's lymphoma.
Details: OBJECTIVES: - Determine the effects of in vivo rituximab purging and maintenance on progression-free survival in patients with relapsed or resistant follicular non-Hodgkin's lymphoma undergoing high-dose chemotherapy. - Determine the effects of this regimen on response rate and overall survival in this patient population. - Determine the effects of in vivo purging with rituximab on molecular remission rates in the hematopoietic product and the patients. - Determine the safety of rituximab in the transplant setting. OUTLINE: This is a randomized, open-label, multicenter study. Patients are stratified according to type of remission (complete vs good partial) and which remission (second vs third). Patients are randomized to one of four treatment arms. All patients receive induction chemotherapy comprising cyclophosphamide IV over 3-4 hours on day 0 or a standard induction chemotherapy regimen. Filgrastim (G-CSF) is administered subcutaneously daily beginning on day 1. Patients are then randomized to receive either in vivo rituximab purging or no purging following restaging after completion of induction. For those patients receiving purging (arms I and II), rituximab is administered IV once weekly for 4 weeks. Peripheral blood stem cells (PBSC) are collected between days 8 and 12 post induction chemotherapy. Within 4 weeks of PBSC collection, patients receive carmustine IV over 2 hours on day -6, etoposide IV over 2 hours on days -5 to -2, cytarabine IV over 5 minutes twice daily on days -5 to -2, and melphalan IV over 10-15 minutes on day -1. (Alternatively, high dose cyclophosphamide and total body irradiation beginning 2-4 weeks after cyclophosphamide or standard induction chemotherapy priming is also allowed.) PBSC are reinfused on day 0. Patients are further randomized to receive either rituximab maintenance or observation only. For those patients receiving maintenance (arms I and III), rituximab is administered IV once every 2 months for 4 doses beginning 30 days after PBSC reinfusion. Patients are followed at 30 days, 3, 6, 9, and 12 months after PBSC transplant, every 6 months for 2 years, and then annually thereafter. PROJECTED ACCRUAL: A total of 460 patients (115 per treatment arm) will be accrued for this study within 5 years.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Relapsed or resistant follicular non-Hodgkin's lymphoma (NHL) - No evidence of transformation to high grade or diffuse large B-cell NHL - CD20 positive with no evidence of transformation - Achievement of complete remission (CR) or very good partial remission (VGPR) following reinduction chemotherapy with any standard regimen - Includes patients who fail to respond to first-line chemotherapy but who achieve CR or VGPR after proceeding directly to second-line chemotherapy - Platelet count greater than 100,000/mm^3 after induction chemotherapy and before randomization - No CNS involvement PATIENT CHARACTERISTICS: Age: - 18 and over Performance status: - WHO 0-1 Life expectancy: - Not specified Hematopoietic: - See Disease Characteristics Hepatic: - Bilirubin normal - ALT no greater than 2 times upper limit of normal (ULN) - Alkaline phosphatase no greater than 2 times ULN - Hepatitis B negative - Hepatitis C negative Renal: - Creatinine no greater than 2 times ULN - BUN no greater than 2 times ULN Cardiovascular: - No inadequate cardiac function Pulmonary: - No inadequate pulmonary function Other: - Not pregnant or nursing - HIV negative - No other uncontrolled serious medical conditions - No other malignancy within the past 5 years except nonmelanoma skin tumors or carcinoma in situ of the cervix PRIOR CONCURRENT THERAPY: Biologic therapy: - More than 12 months since prior CD20 therapy, including rituximab - No prior peripheral blood stem cell transplantation Chemotherapy: - See Disease Characteristics - No more than 3 prior chemotherapy regimens for NHL Endocrine therapy: - Not specified Radiotherapy: - No prior radiotherapy to greater than 30% of bone marrow Surgery: - Not specified
Total Enrollment:
Location and Contact Information:
Overall Study Official:
RuthPettengell, Study Chair, St. Georges Hospital Medical School
Ev. Diakome Krankenhaus gGmBH *Recruiting*
Bremen, , 28239
Germany
Recruiting Karl-Heinz Pflueger 011-49-421-6102-1481
Algemeen Ziekenhuis Middelheim *Recruiting*
Antwerpen, , B-2020
Belgium
Recruiting Robrecht Bock 32-3-280-3484
Staffordshire General Hospital *Recruiting*
Stafford, England, ST16 3SA
United Kingdom
Recruiting P. Revell 44-1785-257-731
Hospital General Universitario "Morales Meseguer" *Recruiting*
Murcia, , 30008
Spain
Recruiting Jose Moraleda 34-968-360-900
UniversitaetsSpital *Recruiting*
Zurich, , CH-8091
Switzerland
Recruiting Christian Taverna 41-1-255-2214
Royal Adelaide Hospital *Recruiting*
Adelaide, South Australia, 5000
Australia
Recruiting Bik To 61-8-8222-3262
University College Hospital *Recruiting*
London, England, WC1E 6AU
United Kingdom
Recruiting Antony Goldstone 44-20-7380-9678
Royal Brisbane and Women's Hospital *Recruiting*
Brisbane, Queensland, 4029
Australia
Recruiting Simon Durrant 61-7-3636-8756
Liverpool University Hospital *Recruiting*
Liverpool, England, L9 7AL
United Kingdom
Recruiting A Petitt 44-151-706-43-63
Rotherham District General Hospital - NHS Trust *Recruiting*
Rotherham, England, S60 2UD
United Kingdom
Recruiting Helen Barker 44-1709-820-000
Singleton Hospital *Recruiting*
Swansea, Wales, SA 2 8QA
United Kingdom
Recruiting S. Al-Ismail 44-1792-285-299
Royal Liverpool and Broadgreen Hospitals *Recruiting*
Liverpool, England, L7 8XP
United Kingdom
Recruiting A. Pettit 44-151-706-4363
Klinikum Oldenburg *Recruiting*
Oldenburg, , D-26133
Germany
Recruiting B. Metzner 494-414-032-614
James Paget Hospital *Recruiting*
Norfolk, England, NR31 6LA
United Kingdom
Recruiting Shalal Sadullah 44-01-493-452-827
Unidad De Oncol/Hemat. Hospital *Recruiting*
Valencia, , 46017
Spain
Recruiting S. Bordes 34-96-386-2500
Pinderfields Hospital NHS Trust *Recruiting*
Wakefield, Scotland, WF1 4DG
United Kingdom
Recruiting P. Hillmen 44-0192-420-1688
University Hospital Kralovske Vinohr *Recruiting*
Prague 10, , 10034
Czech Republic
Recruiting T. Kozak 420-26-716-2292
Zentralklinikum Augsburg *Recruiting*
Augsburg, , DOH-86156
Germany
Recruiting Gunter Schlimok 49-821-400-2353
Belfast City Hospital Trust *Recruiting*
Belfast, Northern Ireland, BT9 7AB
United Kingdom
Recruiting R.J.G. Cuthbert 44-28-9032-9241
Westmead Hospital *Recruiting*
Westmead, New South Wales, 2145
Australia
Recruiting K. Bradstock 61-2-9845-7073
Hospital Clinico Universitario de Valencia *Recruiting*
Valencia, , 46010
Spain
Recruiting Javier Garcia-Conde 34-96-386-2625
Princess Margaret Hospital *Recruiting*
Swindon, England, SN1 4JU
United Kingdom
Recruiting N.E. Blesing 441-793-460-5004
H. Hartziekenhuis V.Z.W. *Recruiting*
Roeselare, , 8800
Belgium
Recruiting Filip Van Aelst 32-51-237111
Centre Henri Becquerel *Recruiting*
Rouen, , 76038
France
Recruiting Herve Tilly 33-2-3208-2223
Hospital Ramon y Cajal *Recruiting*
Madrid, , 28034
Spain
Recruiting D. Garcia-Larana 34-91-336-8263
Royal United Hospital *Recruiting*
Bath, England, BA1 3NG
United Kingdom
Recruiting C. Knechtli 44-1225-824-704
Birmingham Heartlands and Solihull NHS Trust -Teaching *Recruiting*
Birmingham, England, B9 5SS
United Kingdom
Recruiting D.W. Milligan 44-0121-424-2000 ext. 43703 an
Hopital Saint-Louis *Recruiting*
Paris, , 75475
France
Recruiting Christian Gisselbrecht 33-1-4249-9296
Centre Hospitalier Lyon Sud *Recruiting*
Pierre-Benite, , 69495
France
Recruiting Gilles Salles 33-478-861-191
Universitaetsklinik Goettingen *Recruiting*
Goettingen, , D-37075
Germany
Recruiting W. Jung 49-551-396-210
Aberdeen Royal Infirmary *Recruiting*
Aberdeen, Scotland, AB25 2ZN
United Kingdom
Recruiting Dominic Culligan 44-1224-553-394
Hospital de la Santa Cruz I Sant Pau *Recruiting*
Barcelona, , 08025
Spain
Recruiting J. Sierra 34-93-291-9396
Oxford Radcliffe Hospital *Recruiting*
Oxford, England, 0X3 9DU
United Kingdom
Recruiting C. Hatton 44-186-522-6180
Odense University Hospital *Recruiting*
Odense, , DK-5000
Denmark
Recruiting B. Christensen 45-65-412-923
Zentralkrankenhaus *Recruiting*
Bremen, , D-28205
Germany
Recruiting C. Meier 49-421-497-2000
Centro Medico Teknon *Recruiting*
Barcelona, , 08022
Spain
Recruiting P. Vivancos 34-93-290-62-00
Leicester Royal Infirmary *Recruiting*
Leicester, England, LE1 5WW
United Kingdom
Recruiting A. Hunter 0116-258-6602
Chaim Sheba Medical Center *Recruiting*
Tel Hashomer, , 52621
Israel
Recruiting A. Nagler 972-3-530-5380
Hospital Virgen de la Arrixaca *Recruiting*
El Palmar, , 30120
Spain
Recruiting A. Morales 34-968-36-95-00
Royal Bournemouth Hospital *Recruiting*
Bournemouth, England, BH7 7DW
United Kingdom
Recruiting S. Killick 44-1202-303-626
Sydney Cancer Centre at Royal Prince Alfred Hospital *Recruiting*
Sydney, New South Wales, 2050
Australia
Recruiting John Gibson 61-2-9515-8031
University College London Medical School *Recruiting*
London, England, WC1E 6HX
United Kingdom
Recruiting David Linch 44-171-380-9724
Hull Royal Infirmary *Recruiting*
Hull, England, HU3 2KZ
United Kingdom
Recruiting R. Patmore 44-014-8232-8541
Allgemeines Krankenhaus der Stadt Wien *Recruiting*
Vienna, , A-1090
Austria
Recruiting Hildegard Greinix 43-1-404004457
Hopital Rene Dubos *Recruiting*
Pontoise, , 95300
France
Recruiting Yves Kerneis 33-1-30-75-40-40
Waikato Hospital *Recruiting*
Hamilton, , 2020
New Zealand
Recruiting M. Jameson 64-7-839-8604
Nottingham City Hospital NHS Trust *Recruiting*
Nottingham, England, NG5 1PB
United Kingdom
Recruiting A. McMillan 44-115-969-1169
Hospital Cuidad de Jaen *Recruiting*
Jaen, , E-23006
Spain
Recruiting Mufioz Alcala 34-953-299-029
Royal Perth Hospital *Recruiting*
Perth, Western Australia, 6000
Australia
Recruiting Richard Herrmann 61-8-9224-2405
Rigshospitalet *Recruiting*
Copenhagen, , 2100
Denmark
Recruiting Christian Geisler 45-35454286
Institut Gustave Roussy *Recruiting*
Villejuif, , F-94805
France
Recruiting Jean-Henri Bourhis 33-1-42-11-4507
Fremantle Hospital *Recruiting*
Fremantle, Western Australia, 6160
Australia
Recruiting Michael Leahy 61-8-9431-2886
Hospital de Galdakao *Recruiting*
Galdakao-Vizcaya, , 48000
Spain
Recruiting J. Ojanguen 34-94-400-6000
Royal Infirmary *Recruiting*
Glasgow, Scotland, G4 0SF
United Kingdom
Recruiting Grant Mcquaker 44-141-211-4672
Hospital de Gran Canaria Dr. Negrin *Recruiting*
Las Palmas de Gran Canaria, , 350311
Spain
Recruiting Adsuar Campo 34-928-450-001
Queen Elizabeth Hospital *Recruiting*
Woodville, South Australia, 5011
Australia
Recruiting John Norman 61-8-222-6645
Hospital de Cruces *Recruiting*
Barakaldo Bilbao, , E-48903
Spain
Recruiting J. Garcia-Ruiz 34-94-600-6000
Hospital Son Dureta *Recruiting*
Palma de Mallorca, , 07014
Spain
Recruiting A. Garcia 34-971-175-000 ext. 75934
Hospital Virgen de la Vega *Recruiting*
Salamanca, , 37007
Spain
Recruiting M. Gonzalez 34-923-291-200
Southampton General Hospital *Recruiting*
Southampton, England, SO16 6YD
United Kingdom
Recruiting Peter Johnson 44-23-8079-6185
Hospital General - Alicante *Recruiting*
Alicante, , 3010
Spain
Recruiting F. Pascual 34-965-938-300
Hospital Universitari Germans Trias i Pujol *Recruiting*
Barcelona, , 08916
Spain
Recruiting J. Ribera Santasusana 34-93-467-8987
Hospital Universitario Marques de Valdecilla *Recruiting*
Santander, , 39008
Spain
Recruiting E. Conde 34-942-203-450
Royal Melbourne Hospital *Recruiting*
Parkville, Victoria, 3050
Australia
Recruiting Jeffrey Szer 61-3-9342-7737
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology *Recruiting*
Warsaw, , 02-781
Poland
Recruiting Jan Walewski 48-22-546-2223
Kantonsspital Bruderholz *Recruiting*
Bruderholz, , CH-4101
Switzerland
Recruiting Lorenz Jost 41-61-436-3636
CHU Rennes - Hopital Pontchaillou *Recruiting*
Rennes, , 35033
France
Recruiting Thiery Lamy 33-2-99-28-42-91
Centre Regional Francois Baclesse *Recruiting*
Caen, , 14076
France
Recruiting A. Peny 33-2-31-45-50-50
Leeds General Infirmary at Leeds Teaching Hospital NHS Trust *Recruiting*
Leeds, England, LS1 3EX
United Kingdom
Recruiting Gareth Morgan 44-113-243-2799
Canterbury Health Laboratories *Recruiting*
Christchurch, ,
New Zealand
Recruiting W. Patton 64-3-364-0300
Hospital Clinic y Provincial de Barcelona *Recruiting*
Barcelona, , 08036
Spain
Recruiting Armando Guillermo 34-93-227-5575
Tom Baker Cancer Center - Calgary *Recruiting*
Calgary, Alberta, T2N 4N2
Canada
Recruiting Douglas Stewart 403-944-1761
Universitatsklinik - Saarland *Recruiting*
Homburg, , D-66421
Germany
Recruiting F. Hartmannn 49-6841-162-3000
Kettering General Hosptial *Recruiting*
Kettering, Northants, England, NNI6 8UZ
United Kingdom
Recruiting M. Lyttelton 536-492-699
Polyclinique Saint Jean *Recruiting*
Melun, , 77000
France
Recruiting C. Kulecki 33-1-64-14-30-00
Stoke Mandeville Hospital *Recruiting*
Aylesbury-Buckinghamshire, England, HP21 8AL
United Kingdom
Recruiting A.M. O'Hea 44-1-296-315-000
Hospital Clinico Universitario *Recruiting*
Zaragoza, , 50006
Spain
Recruiting Martin Gutierrez 34-976-350-418
Academisch Ziekenhuis der Vrije Universiteit Brussel *Recruiting*
Brussels, , 1090
Belgium
Recruiting Rik Schots 32-2-477-6211
CHU Pitie-Salpetriere *Recruiting*
Paris, , 75651
France
Recruiting Jean Gabarre 33-1-42-169-792
Marienhospital / Ruhr University Bochum *Recruiting*
Herne, , D-44625
Germany
Recruiting U. Graeven 49-2323-499-1661
Hospital Universitario Central de Asturias *Recruiting*
Oviedo, , 33006
Spain
Recruiting D. Fernandez 34-98-510-6100
St. Georges Hospital Medical School *Recruiting*
London, England, SW17 ORE
United Kingdom
Recruiting Ruth Pettengell 44-20-8725-5454
Hospital Universidad Virgen Del Rocio *Recruiting*
Sevilla, , E- 41013
Spain
Recruiting R. Ruisberdejo 34-95-424-8181
K. Dluski Hospital-Medical Academy *Recruiting*
Wroclaw, , 53 439
Poland
Recruiting A. Lange 48-71-621-512
U.Z. Gasthuisberg *Recruiting*
Leuven, , B-3000
Belgium
Recruiting P. Vandenberghe 32-16-345-903
Huddinge University Hospital *Recruiting*
Stockholm, , SE-141 86
Sweden
Recruiting Eva Kimby 46-8-746-1000
CHU de Grenoble - Hopital de la Tronche *Recruiting*
Grenoble, , 38043
France
Recruiting R. Gressin 33-4-7676-5712
Ottawa Regional Cancer Centre *Recruiting*
Ottawa, Ontario, K1H 8L6
Canada
Recruiting Isabelle Bence-Bruckler 613-737-8443
Hospital Universitario San Carlos *Recruiting*
Madrid, , 28040
Spain
Recruiting A. Alvarez-Carmona 34-91-330-3000
Saint Bartholomew's Hospital *Recruiting*
London, England, EC1A 7BE
United Kingdom
Recruiting Thomas Lister 44-20-7601-7462
Guy's and St. Thomas' Hospitals NHS Trust *Recruiting*
London, England, SE1 9RT
United Kingdom
Recruiting Stephen Schey 44-20-795-55-000
Hospital de Mutua de Terrassa *Recruiting*
Terrassa, , 08221
Spain
Recruiting Cristina Estany 34-93-736-5050
Ysbyty Gwynedd *Recruiting*
Bangor, Wales, LL57 2PW
United Kingdom
Recruiting H. Parry 44-1248-384-384 Ext. 4369
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle *Recruiting*
Montpellier, , 34298
France
Recruiting Michel Fabbro 04-67-61-30-63
Complexo Hospitalario Xeral de Vigo *Recruiting*
Vigo Pontevedra, , 36204
Spain
Recruiting C. Lopez 34-986-816-000
Sandwell & West Birminghan NHS Trust *Recruiting*
West Bromwich, England, B71 4HJ
United Kingdom
Recruiting P.J. Stableforth 44 121 5531831
Hospital Universitario Miguel Servet *Recruiting*
Zaragoza, , 50009
Spain
Recruiting D. Felix 34-976-765-500
Ibn-i Sina Hospital *Recruiting*
Ankara, , 06100
Turkey
Recruiting M. Ozcan 90-312-310-3333 Ext. 2121
Centre Leon Berard *Recruiting*
Lyon, , 69373
France
Recruiting Catherine Sebban 33-04-78-782-645
Klinikum Nuernberg - Klinikum Nord *Recruiting*
Nuernberg, , D-90419
Germany
Recruiting Hannes Wandt 49-911-398-3060
Auckland Hospital *Recruiting*
Auckland, , 1
New Zealand
Recruiting T. Hawkins 64-9-307-5499
Pontefract General Infirmary *Recruiting*
Pontefract West Yorkshire, England, WF8 1PL
United Kingdom
Recruiting D. Wright 44-1977-600-600
Princess Margaret Hospital *Recruiting*
Swindon, England, SN1 4JU
United Kingdom
Recruiting N.E. Blesing 441-793-460-5004
Institut Jules Bordet *Recruiting*
Brussels, , 1000
Belgium
Recruiting Dominique Bron 32-2-5413212
Universitair Ziekenhuis Gent *Recruiting*
Ghent, , B-9000
Belgium
Recruiting Fritz Offner 32-92-40-21-25
CHU Liege - Domaine Universitaire du Sart Tilman *Recruiting*
LIEGE, , B-4000
Belgium
Recruiting Yves Beguin 43-66-76-90
Western General Hospital *Recruiting*
Edinburgh, Scotland, EH4 2XU
United Kingdom
Recruiting Michael Mackie 44-131-537-1903
Eberhard Karls Universitaet *Recruiting*
Tuebingen, , D-72076
Germany
Recruiting Ch. Faul 49-7071-29-84087
Hospital de la Princesa *Recruiting*
Madrid, , 28006
Spain
Recruiting R Saenz 34-91-5202200
Huddersfield Royal Infirmary *Recruiting*
Huddersfield, West Yorks, England, HD3 3EA
United Kingdom
Recruiting C. Carter 44-1484-422-191
Hospital Universitario 12 de Octubre *Recruiting*
Madrid, , 28041
Spain
Recruiting J.J. Lahuerta 3491-3908525
Polyclinique Du Parc *Recruiting*
Caen, , 14052
France
Recruiting Levatien 33-2-31-82-82-82
Weston Park Hospital *Recruiting*
Sheffield, England, S1O 2SJ
United Kingdom
Recruiting Linda Evans 44-114-226-5000
Hospital San Pedro de Alcantara *Recruiting*
Caceres, , 10000
Spain
Recruiting Martin Paz 34-927-256-200
CHR Hotel Dieu *Recruiting*
Nantes, , 44093
France
Recruiting Noel Milpied 33-24-008-3272
Saint Georg-Hospital *Recruiting*
Hamburg, , D-20099
Germany
Recruiting Norbert Schmitz 49-40-2890-2005
Centre Hospitalier Universitaire Bretonneau de Tours *Recruiting*
Tours, , 37044
France
Recruiting Philippe Colombat 33-2-47-47-37-12
Hospital General Gregorio Maranon *Recruiting*
Madrid, , 28007
Spain
Recruiting Jose Diez-Martin 34-91-5868000
Hospital Universitario Puerta Del Mar *Recruiting*
Cadiz, , 11000
Spain
Recruiting F. Capote 34-956-242-100
Instituto Portugues de Oncologia de Francisco Gentil - Centro de Lisboa *Recruiting*
Lisboa, , 1099-023 Codex
Portugal
Recruiting F. Da Costa 351-21-722-9800
Medical University Hospital Homburg *Recruiting*
Homburg, , 66421
Germany
Recruiting L. Truemper 49-68-41-160
University Hospital - Salamanca *Recruiting*
Salamanca, , 37007
Spain
Recruiting D. Caballero 34-923-291-316
Clinique Sainte Elisabeth *Recruiting*
Namur, , 5000
Belgium
Recruiting L. Den Bossche 32-81-720-411
Clinique Universitaire De Mont-Godinne *Recruiting*
Mont-Godinne Yvoir, , 5530
Belgium
Recruiting Andre Bosly 32-81-423831
Hospital Virgen de las Nieves *Recruiting*
Granada, , 18014
Spain
Recruiting A. Aguilar 34-958-020-073
Royal Devon and Exeter Hospital *Recruiting*
Exeter, England, EX2 5DW
United Kingdom
Recruiting M. Joyner 44-1392-402-928
Herlev Hospital - University Hospital of Copenhagen *Recruiting*
Copenhagen, , DK-2730
Denmark
Recruiting Hans Johnsen 45-44-88-39-24
Hospital Juan Canalejo *Recruiting*
La Coruna, , 15000
Spain
Recruiting Gomez Varela 34-981-178-000
Centre Hospitalier Regional et Universitaire d'Angers *Recruiting*
Angers, , 49033
France
Recruiting M. Gardembas 33-02-4148-1066
Hospital General de Castellon *Recruiting*
Castellon, , 12004
Spain
Recruiting R. Boyero 34-964-211-000
Bristol Haematology and Oncology Centre *Recruiting*
Bristol, England, BS2 8ED
United Kingdom
Recruiting R. Evely 44-117-923-0000
Hillingdon Hospital *Recruiting*
Uxbridge, England, UB8 3NN
United Kingdom
Recruiting R. Kaczmarski 44-1-895-238-282
Norfolk and Norwich University Hospital *Recruiting*
Norwich, England, NR4 7UY
United Kingdom
Recruiting M. Deane 44-603-286-286
Prince Philip Hospital *Recruiting*
Dyfed, Wales, SA14 8QF
United Kingdom
Recruiting S. Lewis 44-1554-756-567
Hospital Universitario de Getafe *Recruiting*
Madrid, , 28905
Spain
Recruiting J. Garcia 34-91-683-9360
Additional Information:
Study ID Numbers: CDR0000067665; EU-99050,BNLI-EBMT-EBMTLYM1,EBMT-EBMTLYM1
Study Start Date:
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005589
Other Recurrent Grade 3 Follicular Lymphoma Studies:
1. Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
2. Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
3. Monoclonal Antibodies in Treating Patients with Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
4. Rituximab, Autologous Vaccine Therapy, and Sargramostim in Treating Patients With Recurrent or Refractory Follicular B-Cell Lymphoma
5. Rituximab With or Without Interleukin-12 in Treating Patients With Non-Hodgkin's Lymphoma
Related Studies:
Other recurrent grade 3 follicular lymphoma Clinical Trials
Other Clinical Trials
Other Leuven Clinical Trials
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
|
|
|
|
|
|
|
|
